{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-019893","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2025-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.398312+00:00","generated_at":"2026-05-18T06:18:36.778655+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Indaptus Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq notice on July 14, 2025 that closing bid price was ≥$1.00 for 10 consecutive business days (June 27-July 11, 2025).","Previously reported non-compliance on January 31, 2025; had until July 30, 2025 to regain compliance.","Nasdaq considers the bid price deficiency matter now closed.","Regaining compliance removes imminent delisting risk from The Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-019893","json":"https://secwatch.observer/filing/0001641172-25-019893.json","markdown":"https://secwatch.observer/filing/0001641172-25-019893.md","text":"https://secwatch.observer/filing/0001641172-25-019893.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000164117225019893/0001641172-25-019893-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000164117225019893/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:18:36.778655+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}